Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 386

1.

Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.

Abe K, Ishikawa Y, Ishikawa J, Fujiwara M, Kita Y.

Immunol Med. 2019 Dec 3:1-4. doi: 10.1080/25785826.2019.1696644. [Epub ahead of print]

PMID:
31794352
2.

Comparative analysis of TTF-1-binding DNA regions in small cell lung cancer and non-small cell lung cancer.

Hokari S, Tamura Y, Kaneda A, Katsura A, Morikawa M, Murai F, Ehata S, Tsutsumi S, Ishikawa Y, Aburatani H, Kikuchi T, Miyazono K, Koinuma D.

Mol Oncol. 2019 Nov 29. doi: 10.1002/1878-0261.12608. [Epub ahead of print]

3.

Cerebral Insufficiency Caused by Diazoxide in a Premature Neonate with Congenital Hyperinsulinism.

Okada S, Fukunaga S, Ohta H, Furuta T, Hirano R, Motonaga T, Ishikawa Y.

Neuropediatrics. 2019 Nov 27. doi: 10.1055/s-0039-3400975. [Epub ahead of print]

PMID:
31777044
4.

Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma.

Inamura K, Amori G, Yuasa T, Yamamoto S, Yonese J, Ishikawa Y.

Cancer Manag Res. 2019 Jul 25;11:7021-7030. doi: 10.2147/CMAR.S209205. eCollection 2019.

5.

Successful use of oral prostaglandin E1 derivative for maintaining ductus-dependent systemic circulation in a neonate with trisomy 18.

Miyake A, Okada S, Ishikawa Y.

Cardiol Young. 2019 Sep;29(9):1222-1224. doi: 10.1017/S1047951119001902. Epub 2019 Aug 22.

PMID:
31434595
6.

Classification and prognostic stratification of bronchopulmonary neuroendocrine neoplasms.

Oka N, Kasajima A, Konukiewitz B, Sakurada A, Okada Y, Kameya T, Weichert W, Ishikawa Y, Suzuki H, Sasano H, Klöppel G.

Neuroendocrinology. 2019 Aug 19. doi: 10.1159/000502776. [Epub ahead of print]

PMID:
31422400
7.

Prediction of early colorectal cancer metastasis by machine learning using digital slide images.

Takamatsu M, Yamamoto N, Kawachi H, Chino A, Saito S, Ueno M, Ishikawa Y, Takazawa Y, Takeuchi K.

Comput Methods Programs Biomed. 2019 Sep;178:155-161. doi: 10.1016/j.cmpb.2019.06.022. Epub 2019 Jun 22.

PMID:
31416544
8.

Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection.

Sonoda D, Matsuura Y, Ichinose J, Nakao M, Ninomiya H, Mun M, Ishikawa Y, Nakagawa K, Satoh Y, Okumura S.

Cancer Manag Res. 2019 Jul 19;11:6765-6774. doi: 10.2147/CMAR.S213553. eCollection 2019.

9.

Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer.

Koyama J, Horiike A, Yoshizawa T, Dotsu Y, Ariyasu R, Saiki M, Sonoda T, Uchibori K, Nishikawa S, Kitazono S, Yanagitani N, Ninomiya H, Ishikawa Y, Nishio M.

J Thorac Dis. 2019 May;11(5):1919-1928. doi: 10.21037/jtd.2019.04.102.

10.

Refractory Sjögren's syndrome myelopathy successfully treated with subcutaneous tocilizumab: A case report.

Ishikawa Y, Hattori K, Ishikawa J, Fujiwara M, Kita Y.

Medicine (Baltimore). 2019 Jul;98(27):e16285. doi: 10.1097/MD.0000000000016285.

11.

Outcome of patients with functional single ventricular heart after pacemaker implantation: What makes it poor, and what can we do?

Kodama Y, Kuraoka A, Ishikawa Y, Nakamura M, Ushinohama H, Sagawa K, Umemoto S, Hashimoto T, Sakamoto I, Ohtani K, Ide T, Tsutsui H, Ishikawa S.

Heart Rhythm. 2019 Dec;16(12):1870-1874. doi: 10.1016/j.hrthm.2019.06.019. Epub 2019 Jun 25.

PMID:
31252085
12.

Assessing the Efficacy of Very Early Motor Rehabilitation in Children with Down Syndrome.

Okada S, Uejo T, Hirano R, Nishi H, Matsuno I, Muramatsu T, Fujiwara M, Miyake A, Okada Y, Fukunaga S, Ishikawa Y.

J Pediatr. 2019 Oct;213:227-231.e1. doi: 10.1016/j.jpeds.2019.05.038. Epub 2019 Jun 14.

PMID:
31208780
13.

Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab.

Kawashima Y, Nishikawa S, Ninomiya H, Yoshida R, Takano N, Oguri T, Kitazono S, Yanagitani N, Horiike A, Ohyanagi F, Ishikawa Y, Nishio M.

Intern Med. 2019;58(10):1479-1484. doi: 10.2169/internalmedicine.1673-18. Epub 2019 May 15.

14.

Usefulness of Liver Stiffness on Ultrasound Shear-Wave Elastography for the Evaluation of Central Venous Pressure in Children With Heart Diseases.

Terashi E, Kodama Y, Kuraoka A, Ishikawa Y, Nakamura M, Sagawa K, Ishikawa S.

Circ J. 2019 May 24;83(6):1338-1341. doi: 10.1253/circj.CJ-18-1313. Epub 2019 Apr 23.

15.

Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial).

Kondo K, Matsusaka S, Ishihara S, Horie H, Uehara K, Oguchi M, Murafushi K, Ueno M, Mizunuma N, Shimbo T, Kato D, Okuda J, Hashiguchi Y, Nakazawa M, Sunami E, Kawai K, Yamashita H, Okada T, Ishikawa Y, Fujii M, Nakajima T.

Radiother Oncol. 2019 May;134:199-203. doi: 10.1016/j.radonc.2019.02.006. Epub 2019 Feb 26.

PMID:
31005216
16.

Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.

Konishi T, Shinozaki E, Murofushi K, Taguchi S, Fukunaga Y, Nagayama S, Fujimoto Y, Akiyoshi T, Nagasaki T, Suenaga M, Chino A, Kawachi H, Yamamoto N, Ishikawa Y, Oguchi M, Ishizuka N, Ueno M, Yamaguchi K.

Ann Surg Oncol. 2019 Aug;26(8):2507-2513. doi: 10.1245/s10434-019-07342-7. Epub 2019 Apr 8.

PMID:
30963400
17.

Erythema Nodosum Masking Kawasaki Disease with an Initial Manifestation of Skin Lesions.

Okada S, Ishikawa Y, Shimomura M, Sunagawa S, Hirano R, Fukunaga S, Miyake A, Okada Y, Maki T.

Yonsei Med J. 2019 Mar;60(3):312-314. doi: 10.3349/ymj.2019.60.3.312.

18.

Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status.

Fukuda K, Takeuchi S, Arai S, Katayama R, Nanjo S, Tanimoto A, Nishiyama A, Nakagawa T, Taniguchi H, Suzuki T, Yamada T, Nishihara H, Ninomiya H, Ishikawa Y, Baba S, Takeuchi K, Horiike A, Yanagitani N, Nishio M, Yano S.

Cancer Res. 2019 Apr 1;79(7):1658-1670. doi: 10.1158/0008-5472.CAN-18-2052. Epub 2019 Feb 8.

PMID:
30737231
19.

Identification of genes and pathways, including the CXCL2 axis, altered by DNA methylation in hepatocellular carcinoma.

Subat S, Mogushi K, Yasen M, Kohda T, Ishikawa Y, Tanaka H.

J Cancer Res Clin Oncol. 2019 Mar;145(3):675-684. doi: 10.1007/s00432-018-2824-0. Epub 2018 Dec 18.

PMID:
30564899
20.

Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method.

Takamatsu M, Kawachi H, Yamamoto N, Kobayashi M, Toyama Y, Maekawa T, Chino A, Saito S, Ueno M, Takazawa Y, Ishikawa Y.

Mod Pathol. 2019 May;32(5):675-683. doi: 10.1038/s41379-018-0189-1. Epub 2018 Dec 14.

PMID:
30552417

Supplemental Content

Loading ...
Support Center